← SynDRA
ICOMUCRET
SynDRA canonical compound SYN0020410 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | LTB4R2 |
|---|
| Mechanism of action | mucin production enhancer |
|---|
All known targets
Mechanisms of action (all sources)
- mucin production enhancer
Cross-references
Synonyms
- 15(s)-hete
- AL-12959
- 15(S)-hydroxyeicosatetraenoic acid (ophthalmic, dry eye), Alcon
- PROCALYX
- 15(S)-HETE
- 15(S)-Hydroxyeicosatetraenoic acid
- Icomucret [INN]
- Icomucret [USAN:INN]
- Icomucret (USAN)
- ICOMUCRET [USAN]
- (15S)-15-Hydroxy-5,8,11-cis-13-trans-eicosatetraenoate
- CHEBI:15558
- (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid
- (15S)-hydroxyeicosa-(5Z,8Z,11Z,13E)-tetraenoic acid
- icomucretum
- RefChem:437473
- (15S)-15-Hydroxy-5,8,11-cis-13-trans-icosatetraenoate
- UNII-44JHK6G39Q
- (S)-15-HETE
- starbld0018619
- BSPBio_001337
- SCHEMBL994674
- BML1-B09
- GTPL3401
- orb1696960
- (15S,5Z,8Z,11Z,13E)-15-Hydroxyeicosatetraenoic acid
- HMS1361C19
- HMS1791C19
- HMS1989C19
- HMS3402C19
- 5Z,8Z,11Z,13E,15S)-15-Hydroxyicosa-5,8,11,13-tetraenoic acid
- BDBM50421764
- LMFA03060001
- MFCD00063590
- AKOS040752060
- IDI1_033807
- NCGC00161242-01
- NCGC00161242-02
- NCGC00161242-03
Look up ICOMUCRET in the interactive SynDRA portal →